Clinical Trials
27 trialsNCT06320353 2024-03-20
Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma
R-Pharm
Phase 3 Unknown
NCT06307093 2024-03-12
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
Phase 1 Unknown
NCT04544748 2024-03-06
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
Phase 1 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT02858921 2023-08-30
Neo Trio
Melanoma Institute Australia
Phase 2 Unknown
NCT05990634 2023-08-14
LifeChamps Feasibility Study
Region Stockholm
Phase NA Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT05539157 2023-04-04
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Immorna Biotherapeutics, Inc.
Phase 1 Unknown
NCT05750511 2023-03-01
TRIM
Dermatologic Cooperative Oncology Group
Unknown
NCT01955915 2022-10-12
Blood Vessel Patterns in Small Choroidal Tumors
OHSU Knight Cancer Institute
Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT03934827 2022-08-11
MICROBIOME
Imperial College London
Phase 1 Unknown
NCT05097378 2021-10-28
PREMIUM
Cambridge University Hospitals NHS Foundation Trust
Phase 2 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT04136470 2020-08-10
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
Unknown
NCT04268368 2020-02-17
ICI-DISCOVER
Università Politecnica delle Marche
Unknown
NCT04169867 2019-11-20
Polish Microbiome Map
Ardigen
Unknown
NCT04001725 2019-11-13
OPTIMAL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown
NCT03454282 2019-02-26
DIgesT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Unknown
NCT03822988 2019-01-30
PADAONCODERM
Central Hospital, Nancy, France
Unknown
NCT00769613 2013-12-18
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00637637 2013-08-12
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01295463 2013-08-12
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
National Cancer Institute (NCI)
Unknown
NCT01584115 2012-04-25
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Instituto de Investigação em Imunologia
Phase 1/2 Unknown
NCT01316744 2011-05-13
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01265472 2010-12-23
Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy
Rambam Health Care Campus
Unknown
NCT00294476 2006-10-12
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
GammaCan
Phase 2 Unknown